PAPER Zeng L, Tallaksen-Greene SJ, Wang B, Albin RL, Paulson HL
SEARCH RESULTS
329930 RESULTS
PAPER Li DW, Liu ZQ, Chen W, Yao M, Li GR
Association of glycogen synthase kinase-3β with Parkinson's disease (review).
Mol Med Rep. 2014 Jun;9(6):2043-50. Epub 2014 Mar 28 PubMed: 24681994PAPER O'Flanagan CH, Morais VA, Wurst W, De Strooper B, O'Neill C
The Parkinson's gene PINK1 regulates cell cycle progression and promotes cancer-associated phenotypes.
Oncogene. 2014 Mar 31;0 PubMed: 24681957PAPER Kondadi AK, Wang S, Montagner S, Kladt N, Korwitz A, Martinelli P, Herholz D, Baker MJ, Schauss AC, Langer T, Rugarli EI
Loss of the m-AAA protease subunit AFG₃L₂ causes mitochondrial transport defects and tau hyperphosphorylation.
EMBO J. 2014 May 2;33(9):1011-26. Epub 2014 Mar 28 PubMed: 24681487PAPER Kachroo A, Schwarzschild MA
Allopurinol reduces levels of urate and dopamine but not dopaminergic neurons in a dual pesticide model of Parkinson's disease.
Brain Res. 2014 May 14;1563:103-9. Epub 2014 Mar 26 PubMed: 24680743PAPER Tsivgoulis G, Bonakis A, Papathanasiou MA, Chondrogianni M, Papageorgiou SG, Voumvourakis K, Stefanis L
Magnetic resonance imaging reveals Creutzfeldt-Jakob disease in a patient with apparent dementia with Lewy bodies.
J Neurol Sci. 2014 May 15;340(1-2):130-2. Epub 2014 Mar 11 PubMed: 24680564PAPER Mackin RS, Nelson JC, Delucchi KL, Raue PJ, Satre DD, Kiosses DN, Alexopoulos GS, Arean PA
Association of Age at Depression Onset with Cognitive Functioning in Individuals with Late-Life Depression and Executive Dysfunction.
Am J Geriatr Psychiatry. 2014 Feb 26; PubMed: 24680502PAPER González-Colaço Harmand M, Meillon C, Rullier L, Avila-Funes JA, Bergua V, Dartigues JF, Amieva H
Cognitive decline after entering a nursing home: a 22-year follow-up study of institutionalized and noninstitutionalized elderly people.
J Am Med Dir Assoc. 2014 Jul;15(7):504-8. Epub 2014 Mar 26 PubMed: 24679926PAPER Hacksell U, Burstein ES, McFarland K, Mills RG, Williams H
On the Discovery and Development of Pimavanserin: A Novel Drug Candidate for Parkinson's Psychosis.
Neurochem Res. 2014 Mar 30; PubMed: 24682754PAPER Schapansky J, Nardozzi JD, Felizia F, LaVoie MJ
Membrane recruitment of endogenous LRRK2 precedes its potent regulation of autophagy.
Hum Mol Genet. 2014 Aug 15;23(16):4201-14. Epub 2014 Mar 27 PubMed: 24682598PAPER Bhidayasiri R, Mekawichai P, Jitkritsadakul O, Panyakaew P, Kaewwilai L, Boonrod N, Petchrutchatachart S, Jagota P, Boonpeng K, Singmaneesakulchai S, Setthawatcharawanich S
Nocturnal journey of body and mind in Parkinson's disease: the manifestations, risk factors and their relationship to daytime symptoms. Evidence from the NIGHT-PD study.
J Neural Transm. 2014 Mar 31; PubMed: 24682359PAPER Campbell AW
Parkinson's Disease: A Brief Review.
Adv Mind Body Med. 2014 Spring;28(2):4-5. PubMed: 24681998PAPER Smith KM, Dahodwala N
Sex differences in Parkinson's disease and other movement disorders.
Exp Neurol. 2014 Mar 28; PubMed: 24681088PAPER Wu Y, Guo XY, Wei QQ, Song W, Chen K, Cao B, Ou RW, Zhao B, Shang HF
Determinants of the quality of life in Parkinson's disease: results of a cohort study from Southwest China.
J Neurol Sci. 2014 May 15;340(1-2):144-9. Epub 2014 Mar 14 PubMed: 24679837PAPER Nordberg A, Forsberg A, Engler H
Amyloid imaging in MCI patients
Neurobiol Aging 2006; 27(Suppl 1):S6.Current Filters
No filters selected